The raw materials that are used in the production of bulk drugs are known as pharmaceutical intermediates. They are produced during the synthesis of active pharmaceutical ingredient (API) as a byproduct.
The rising demand to treat chronic diseases increases the requirements of pharmaceutical intermediates. Additionally the demand for APIs in the coming years will also rise due to surging prevalence of infectious diseases which in turn will bolster the growth of the global pharmaceutical intermediate market.
The global pharmaceutical intermediates market is estimated to exhibit a CAGR of 7.2% between 2023 to 2032.
The pharmaceutical intermediates market size was estimated to be US$ 29.5 billion in 2021.
Major players in the global pharmaceutical intermediates market are BASF SE, Lonza Group, Evonik Industries AG, Cambrex Corporation, DSM, Aceto, Albemarle, Corporation, Vertellus, Chemcon Speciality Chemicals Ltd., Chiracon GmbH, Life Sciences Private Limited and others.
Copyright © 2023 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved